Senior Director, Investor Relations

Description de l'emploi

Gilead Sciences, Inc. is a research-based biopharmaceutical company founded in 1987. Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development. Our scientific focus has resulted in marketed products that are benefiting millions of people, a pipeline of late-stage drug candidates, and unmatched patient access programs to ensure medications are available to those who could otherwise not afford them. By joining Gilead, you will further our mission to address unmet medical needs and improve life by advancing the care of patients with life-threatening diseases.

Senior Director, Investor Relations

We are seeking a Sr. Director, Investor Relations for our Foster City Campus.

The Sr. Director of Investor Relations will be responsible for evolving and executing a strategic Investor Relations program that is already recognized as best-in-class in biotech. The Sr. Director will manage all day-to-day responsibilities for Gilead’s investor relations program, serving as the primary contact for coverage and targeted sell-side analysts and for most buy-side holders and targets. The Sr. Director will manage a team of five and interact routinely with Gilead’s senior executives. The position reports to the Senior Vice President of Treasury and Investor Relations.

Responsibilities include, but are not limited to:

• Manage quarterly earnings process and deliverables including script, deck and Q&A materials.
• Design and execute an impactful investor engagement program, including investor conferences, non-deal roadshows, analyst days, annual meeting, on-site meetings and other events.
• Deliver concise and impactful communications to support Gilead participation at scientific conferences and pre-clinical or clinical data updates.
• Support executives’ participation at investor conferences, including preparation of Q&A materials and travel to conferences.
• Conduct peer and competitive analysis of clinical pipelines and business models.
• Innovate and evolve IR program always in full compliance with all regulatory requirements surrounding investor communications.
• Deliver highly responsive and accurate communications to in-bound inquiries from all stakeholders (sell-side, buy-side, retail, employees, executives)
• Manage and develop the investor relations’ team.

Skillset:

Excellent attention to detail, with very strong verbal and interpersonal communication skills. Expert in excel and PowerPoint, with ability to understand and interpret financial statements and valuation models. Must be able to independently develop clear, concise and error-free word, PowerPoint and excel documents. Ability to work independently, lead meetings and work cross-functionally.

Specific Education and Experience

• Typically requires a BA degree in Finance, Science or relevant field and minimum 14 years of relevant experience or an MBA and/or CFA with 12 years of related experience.
• Experience in the biotech or pharmaceutical industry and in analyzing and summarizing clinical data are preferred but not essential.